Failure of 125I-tracer selective monoclonal antibody levels on a whole blood matrix to predict rejection or nephrotoxic episodes in renal transplant patients under anti-lymphocyte globulin and prednisone therapy
Stiller, C.; Keown, P.
Transplantation Proceedings 22(3): 1253-1254
1990
ISSN/ISBN: 0041-1345 PMID: 2349687 Document Number: 356037
Document emailed within 1 workday
Related Documents
Tsuji, K.; Nose, Y.; Kusama, M. 1983: Regulation of graft rejection using anti-lymphocyte monoclonal antibody Nihon Rinsho. Japanese Journal of Clinical Medicine 41(4): 834-840Hourmant, M.; Bedrossian, J.; Durand, D.; Kessler, M.; Le Branchu, Y.; Caudrelier, P.; Simi, B.; Soulillou, J.P. 1995: Multicenter comparative study of an anti-LFA-1 adhesion molecule monoclonal antibody and antithymocyte globulin in prophylaxis of acute rejection in kidney transplantation Transplantation Proceedings 27(1): 864
Noël, C.; Hazzan, M.; Coppin, M.C.; Pruvot, F.R.; Bridoux, F.; Lelièvre, G. 1995: Renal transplant artery thrombosis following treatment of allograft rejection with monoclonal anti-CD3 antibodies (OKT3) Transplantation Proceedings 27(4): 2438-2439
Wang, X.H.; Xie, T. 1993: Anti-CD3 and -CD4 monoclonal antibody in the treatment of steroid-resistant renal allograft rejection Chinese Medical Journal 106(11): 821-824
Veremis, S.A.; Maddux, M.S.; Tang, I.Y.; Millner, S.N.; Prasad, R.; Pollak, R.; Mozes, M.F. 1989: Comparison of cyclosporine (CSA) blood levels and RIA/HPLC ratios among renal transplant patients with normal allograft function, CSA nephrotoxicity or rejection Transplantation Proceedings 21(1 Part 2): 1476-1477
McLigeyo, S.O.; Notghi, A.; Anderton, J.L.; Dick, J. 1990: Acute renal allograft rejection: the role of monoclonal antibodies in treatment: experience with orthoclonal anti-T3 cell antibody East African Medical Journal 67(9): 667-673
Weimer, R.; Daniel, V.; Pomer, S.; Opelz, G. 1989: B lymphocyte response as an indicator of acute renal transplant rejection. I. Immunoglobulin-secreting cells in peripheral blood Transplantation 48(4): 569-572
Lee, C.J.; Yoshimura, N.; Hamashima, T.; Ohsaka, Y.; Oka, T. 1990: Effect of selective administration of monoclonal anti-T-cell antibody on renal allografts in RAT: preliminary report Nihon Geka Gakkai Zasshi 91(10): 1658
Homan van der Heide, J.J.; Bilo, H.J.; Donker, A.J.; Wilmink, J.M.; Sluiter, W.J.; Tegzess, A.M. 1992: The effects of dietary supplementation with fish oil on renal function and the course of early postoperative rejection episodes in cyclosporine-treated renal transplant recipients Transplantation 54(2): 257-263
Ohtsuka, K.; Yasunami, Y.; Ikehara, Y.; Nagai, T.; Kodama, S.; Maki, T.; Tomita, A.; Abo, T.; Ikeda, S. 1997: Expansion of intermediate T cell receptor cells expressing interleukin-2 receptor alpha- beta+, CD8alpha+ beta+, and lymphocyte function-associated antigen-1+ in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: prevention of rejection with anti-interleukin-2 receptor beta monoclonal antibody treatment Transplantation 64(4): 633-639
Troppmann, C.; Almond, P.S.; Payne, W.D.; Dunn, D.L.; Gores, P.F.; Gruessner, R.W.; Sutherland, D.E.; Matas, A.J.; Najarian, J.S. 1993: Does acute tubular necrosis affect renal transplant outcome? the impact of rejection episodes Transplantation Proceedings 25(1 Part 2): 905
McDiarmid, S.V.; Millis, M.; Terashita, G.; Ament, M.E.; Busuttil, R.; Terasaki, P. 1990: Low serum OKT3 levels correlate with failure to prevent rejection in orthotopic liver transplant patients Transplantation Proceedings 22(4): 1774-1776
D'Alessandro, A.M.; Kalayoglu, M.; Pirsch, J.D.; Corwith, C.; Knechtle, S.J.; Reed, A.; Belzer, F.O. 1991: FK 506 rescue therapy for resistant rejection episodes in liver transplant recipients Transplantation Proceedings 23(6): 2987-2988
Sawada, T.; Hashimoto, S. 2007: Human monoclonal antibody to B-lymphocyte stimulator (belimumab) and humanized anti-LFA-1 monoclonal antibodies (efalizumab) Nihon Rinsho. Japanese Journal of Clinical Medicine 65(7): 1239-1242
Kovarik, J.; Zlabinger, G.J.; Wolfram, J.; Pecherstorfer, M.; Watschinger, B.; Traindl, O.; Pohanka, E.; Sonnleitner, A.; Ulrich, W. 1989: OKT3 monoclonal antibody treatment in renal transplant recipients--clinical experience in 49 patients Transplantation Proceedings 21(1 Part 2): 1748-1752
Tellis, V.A.; Matas, A.J.; Quinn, T.A.; Glicklich, D.; Weiss, R.J.; Soberman, R.J.; Veith, F.J. 1987: Antilymphoblast globulin treatment of steroid-resistant rejection in cyclosporine-immunosuppressed renal transplant recipients Transplantation Proceedings 19(1 Part 3): 1892
Snow, E.C.; Mond, J.J.; Subbarao, B. 1986: Enhancement by monoclonal anti-Lyb-2 antibody of antigen-specific B lymphocyte expansion stimulated by TNP-Ficoll and T lymphocyte-derived factors Journal of Immunology 137(6): 1793-1796
Coon, M.J.; England, B.G.; Annesley, T.M.; Giacherio, D.A. 1987: Interference by goat-derived anti-lymphocyte globulin in a double-antibody radioimmunoassay of digoxin Clinical Chemistry 33(4): 619-621
Pierson, R.N.; Kasper-Konig, W.; Tew, D.N.; Young, V.K.; Dunning, J.J.; Horsley, J.; Carey, N.R.; Wallwork, J.; White, D.J. 1997: Hyperacute lung rejection in a pig-to-human transplant model: the role of anti-pig antibody and complement Transplantation 63(4): 594-603
Kargi, A.; Yalcin, A.D.; Erin, N.; Savas, B.; H. Hüseyin Polat; Gorczynski, R.M. 2012: IL8 and Serum Soluble Trail Levels Following Anti-VEGF Monoclonal Antibody Treatment in Patients With Metastatic Colon Cancer Clinical Laboratory 58(5-6): 501-505